The Risk in Estimating Biocompatibility
For the past ten years, concurrent with the growth of artificial organ engineering for body function replacement, there has been an extremely haphazard development of equipment for lung function replacement, bypass and heart pumps, artificial kidneys, and artificial liver and perfusion equipment. Allied to these design studies by clinicians and bioengineers has been the ever-present and growing awareness that the problem of bio-compatibility of devices to which flowing blood, tissues, or bone are directly exposed has been attacked in the most haphazard way.
KeywordsSugar Cellulose Toxicity Albumin Manifold
Unable to display preview. Download preview PDF.
- Domingo, R. T. 1963: Gear take-up heart pumps—avoidance with internal shear forces. Trans. Amer. Soc. Artif. Int. Organs 9: 275.Google Scholar
- Kwan-Gett, C., Bademann, D, K., Donovan, F. M., Eastwood, N., Foote, J. L., Kawai, J., Kessle, T. R., Kralios, A. C., Peters, J. L., Van Kampen, K. R., Wong, H. K., Zwart, H. H. J., and Kolff, W. J. 1971: Trans. Amer. Soc. Artif. Int. Organs 17: 474.Google Scholar
- Longmore, D. B. 1965: Pulsatile flow pump, Lancet, May 15, p. 1048.Google Scholar
- Longmore, D. B. 1969: Cavitation in blood pumps. Nature 222: 5188.Google Scholar
- Lyman, D. J., Kwann-Gett, C., Zwart, H. H. J., Bland, A., Eastwood, N., Kwai, J., and Kolff, W. J. 1971: Trans. Amer. Soc. Artif Int. Organs 17: 456.Google Scholar
- Martin, A. M., Mum, W. M., Ballantine, F., and Courtney, J. M. 1971: ‘Plastics in Medicine and Surgery’. Symposium, University of Newcastle Medical School, Newcastle, September 15th. The Plastics Institute, London.Google Scholar